Walleye Capital LLC Corcept Therapeutics Inc Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$22.21 - $34.48 $292,927 - $454,756	13,189 New	13,189 $428,000
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $462,755 - $529,770	-23,514 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $469,574 - $574,447	23,514 New	23,514 $517,000
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $173,629 - $241,122	-17,174 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.06 - $16.96 $207,118 - $291,271	17,174 New	17,174 $207,000

346

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.35B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.